Abraham Domb

Title: Abraham Domb: Innovator in Delayed Release Technologies

Introduction

Abraham Domb is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the area of drug delivery systems. His innovative work focuses on the development of devices and compositions that enhance the efficacy of macromolecules in medical applications.

Latest Patents

Domb holds a patent for the "Delayed/sustained release of macromolecules." This invention concerns novel, delayed/sustained release devices and compositions, including methods of their manufacture and use. The compositions include macromolecules, particularly polypeptide pharmaceuticals, and an initially partially-hydrated, non-biodegradable, hydrogel rate-limiting membrane. This patent represents a significant advancement in the field of drug delivery, offering new possibilities for the administration of therapeutic agents.

Career Highlights

Abraham Domb has had a distinguished career, working with Syntex (U.S.A.) Inc., where he has been able to apply his expertise in pharmaceutical innovations. His work has contributed to the development of advanced drug delivery systems that improve patient outcomes and enhance the effectiveness of treatments.

Collaborations

Domb has collaborated with various professionals in his field, including Lynda M. Sanders, to further advance the research and development of innovative pharmaceutical technologies. Their combined efforts have led to significant advancements in the understanding and application of sustained release mechanisms.

Conclusion

Abraham Domb's contributions to the field of pharmaceutical technology, particularly through his patent on delayed release systems, highlight his role as an innovator. His work continues to influence the development of effective drug delivery methods, showcasing the importance of innovation in healthcare.